Woman Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective is to determine clinical benefit rate in patients with AR+ triple-negative breast cancer (TNBC). El objetivo principal es determinar la tasa de beneficio clínico en pacientes con cáncer de mama RA+ triple negativo.
Inclusion criteria
- Breast Cancer,Cáncer de mama